Search results
Rolf Martin Zinkernagel AC (born 6 January 1944) is a professor of experimental immunology at the University of Zurich. Along with Peter C. Doherty, he shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells.
The Nobel Prize in Physiology or Medicine 1996 was awarded jointly to Peter C. Doherty and Rolf M. Zinkernagel "for their discoveries concerning the specificity of the cell mediated immune defence"
Rolf M. Zinkernagel (born January 6, 1944, Basel, Switzerland) is a Swiss immunologist and pathologist who, along with Peter C. Doherty of Australia, received the Nobel Prize for Physiology or Medicine in 1996 for their discovery of how the immune system distinguishes virus -infected cells from normal cells.
- The Editors of Encyclopaedia Britannica
Rolf M. Zinkernagel, University of Zurich, was awarded the 1996 Nobel Prize for Physiology or Medicine jointly with Peter C. Doherty (AAI '76) for "their discoveries concerning the specificity of the cell mediated immune defense."
Rolf M. Zinkernagel. The Nobel Prize in Physiology or Medicine 1996. Born: 6 January 1944, Basel, Switzerland. Affiliation at the time of the award: University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland.
People also ask
Who is Rolf Martin Zinkernagel?
Who is Dr Zinkernagel?
Why did Rolf Zinkernagel and Peter Doherty win a Nobel Prize?
Was the field in a mess before Zinkernagel & Doherty's groundbreaking research?
Curriculum Vitae. Rolf M. Zinkernagel, born January 6, 1944, Basel, Switzerland. Address: Institute of Experimental Immunology, Department of Pathology, University of Zurich, University Hospital, Sternwartstrasse 2, 8091 Zurich, Switzerland. Academic Education.
Dr. Rolf M. Zinkernagel is professor emeritus in the Institute of Experimental Immunology at the University of Zurich. Dr. Zinkernagel is renowned for his discovery of how the immune system recognizes virus-infected cells, showing that T cells can only recognize viral antigens if they are presented in the context of the major histocompatibility ...
